Clinical trial · Observational
Chronic Myelod Leukemia Registry at Asan Medical Center
Prospective Observational Cohort Registry for Patients With Chronic Myeloid Leukemia at Asan Medical Center
NCT01761695CI-TRIAL-00033872terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The PI resigned the institute. The rest investigators at the institute decided to terminate the study.
Summary
Brief summary (as posted)
The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for chronic myeloid leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leukemia, Chronic Myeloid | Chronic Myeloid Leukemia, BCR-ABL1 Positive | ALIAS | 0.90 |
| Myeloid Leukemia, Chronic, Accelerated Phase | Myeloid Leukemia | ONTOLOGY_EXACT | 0.85 |
| Myeloid Leukemia, Chronic, Chronic Phase | Myeloid Leukemia | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diagnosed as CML | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- CML CP
- description
- Diagnosed as CML with chronic phase
- interventionNames
- Other: Diagnosed as CML
- label
- CML AP
- description
- Diagnosed as CML with accelerated phase
- interventionNames
- Other: Diagnosed as CML
- label
- CML BC
- description
- Diagnosed as CML with blast crisis
- interventionNames
- Other: Diagnosed as CML
- label
- CML other
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * All patients who are diagnosed and/or treated as chronic myeloid leukemia at Asan Medical Center * 15 years of age and over * All patients who give written consent according to guidelines at Asan Medical Center committee on human research Exclusion Criteria: * Patients who refuse to give consent to registering
References
Publications (0)
Data not yet available
No reference posted for this study.